545 related articles for article (PubMed ID: 27245104)
1. Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence.
Dou R; Ng K; Giovannucci EL; Manson JE; Qian ZR; Ogino S
Br J Nutr; 2016 May; 115(9):1643-60. PubMed ID: 27245104
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D in thyroid tumorigenesis and development.
Clinckspoor I; Verlinden L; Mathieu C; Bouillon R; Verstuyf A; Decallonne B
Prog Histochem Cytochem; 2013 Aug; 48(2):65-98. PubMed ID: 23890557
[TBL] [Abstract][Full Text] [Related]
3. The burgeoning role of cytochrome P450-mediated vitamin D metabolites against colorectal cancer.
Wang P; Qin X; Liu M; Wang X
Pharmacol Res; 2018 Jul; 133():9-20. PubMed ID: 29719203
[TBL] [Abstract][Full Text] [Related]
4. Cytochromes P450 are essential players in the vitamin D signaling system.
Schuster I
Biochim Biophys Acta; 2011 Jan; 1814(1):186-99. PubMed ID: 20619365
[TBL] [Abstract][Full Text] [Related]
5. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
6. The roles of cytochrome P450 enzymes in prostate cancer development and treatment.
Chen TC; Sakaki T; Yamamoto K; Kittaka A
Anticancer Res; 2012 Jan; 32(1):291-8. PubMed ID: 22213318
[TBL] [Abstract][Full Text] [Related]
7. The current role and therapeutic targets of vitamin D in gastrointestinal inflammation and cancer.
Cai GH; Li MX; Lu L; Yi Chan RL; Wang JH; Cho CH
Curr Pharm Des; 2015; 21(21):2917-23. PubMed ID: 26004419
[TBL] [Abstract][Full Text] [Related]
8. Reprint of "Vitamin D deficiency in pregnant women impairs regulatory T cell function".
Vijayendra Chary A; Hemalatha R; Seshacharyulu M; Vasudeva Murali M; Jayaprakash D; Dinesh Kumar B
J Steroid Biochem Mol Biol; 2015 Apr; 148():194-201. PubMed ID: 25644204
[TBL] [Abstract][Full Text] [Related]
9. The role of vitamin D and VDR in carcinogenesis: Through epidemiology and basic sciences.
Bandera Merchan B; Morcillo S; Martin-Nuñez G; Tinahones FJ; Macías-González M
J Steroid Biochem Mol Biol; 2017 Mar; 167():203-218. PubMed ID: 27913313
[TBL] [Abstract][Full Text] [Related]
10. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
Smolders J; Schuurman KG; van Strien ME; Melief J; Hendrickx D; Hol EM; van Eden C; Luchetti S; Huitinga I
J Neuropathol Exp Neurol; 2013 Feb; 72(2):91-105. PubMed ID: 23334593
[TBL] [Abstract][Full Text] [Related]
11. The anti-cancer actions of vitamin D.
Chiang KC; Chen TC
Anticancer Agents Med Chem; 2013 Jan; 13(1):126-39. PubMed ID: 23094926
[TBL] [Abstract][Full Text] [Related]
12. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Vitamin D hydroxylases gene expression by 1,25-dihydroxyvitamin D3 and cyclic AMP in cultured human syncytiotrophoblasts.
Avila E; Díaz L; Barrera D; Halhali A; Méndez I; González L; Zuegel U; Steinmeyer A; Larrea F
J Steroid Biochem Mol Biol; 2007 Jan; 103(1):90-6. PubMed ID: 17079137
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D3 derivatives with adamantane or lactone ring side chains are cell type-selective vitamin D receptor modulators.
Inaba Y; Yamamoto K; Yoshimoto N; Matsunawa M; Uno S; Yamada S; Makishima M
Mol Pharmacol; 2007 May; 71(5):1298-311. PubMed ID: 17325131
[TBL] [Abstract][Full Text] [Related]
16. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
17. Non-classical mechanisms of transcriptional regulation by the vitamin D receptor: insights into calcium homeostasis, immune system regulation and cancer chemoprevention.
Dimitrov V; Salehi-Tabar R; An BS; White JH
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():74-80. PubMed ID: 23911725
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of colorectal neoplasia by estrogen: potential role of vitamin D activity.
Protiva P; Cross HS; Hopkins ME; Kállay E; Bises G; Dreyhaupt E; Augenlicht L; Lipkin M; Lesser M; Livote E; Holt PR
Cancer Prev Res (Phila); 2009 Jan; 2(1):43-51. PubMed ID: 19139017
[TBL] [Abstract][Full Text] [Related]
19. New insights into the mechanisms of vitamin D action.
Christakos S; Dhawan P; Liu Y; Peng X; Porta A
J Cell Biochem; 2003 Mar; 88(4):695-705. PubMed ID: 12577303
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer.
McCullough ML; Bostick RM; Mayo TL
Annu Rev Nutr; 2009; 29():111-32. PubMed ID: 19400699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
